AI Article Synopsis
- Head and neck squamous cell carcinoma (HNSCC) is a complex cancer with subtle early symptoms and a lack of effective screening methods, leading to low survival rates.
- HNSCC tumors grow quickly and are aggressive, often not responding well to current treatments.
- Histone posttranslational modifications (HPTMs) are crucial in the development and progression of HNSCC, and targeting these modifications with new drugs shows promise for improving treatment outcomes and patient prognosis.
Article Abstract
The pathogenesis of head and neck squamous cell carcinoma (HNSCC) is notably complex. Early symptoms are often subtle, and effective early screening methods are currently lacking. The tumors associated with HNSCC develop rapidly, exhibit high aggressiveness, and respond poorly to existing treatments, leading to low survival rates and poor prognosis. Numerous studies have demonstrated that histone posttranslational modifications (HPTMs), including acetylation, methylation, phosphorylation, and ubiquitination, play a critical role in the occurrence and progression of HNSCC. Moreover, targeting histone posttranslationally modified molecules with specific drugs has shown potential in enhancing therapeutic outcomes and improving prognosis, underscoring their significant clinical value. This review aims to summarize the role of histone posttranslational modifications in the pathogenesis and progression of HNSCC and to discuss their clinical significance, thereby providing insights into novel therapeutic approaches and drug development for this malignancy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11580233 | PMC |
| http://dx.doi.org/10.1186/s13148-024-01785-w | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!